Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors
Delord, Jean-Pierre, Italiano, Antoine, Awada, Ahmad, Aftimos, Philippe, Houédé, Nadine, Lebbé, Céleste, Pages, Celine, Lesimple, Thierry, Dinulescu, Monica, Schellens, Jan H. M., Leijen, Suzanne,Journal:
Targeted Oncology
DOI:
10.1007/s11523-020-00768-0
Date:
November, 2020
File:
PDF, 733 KB
2020